hotspot -WSS

hotspot

author：comprehensive 2025-10-01 00:49:26 - browse：5

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Canadian Prime Minister Justin Trudeau separating from wife, Sophie

WSS

Mitch McConnell episode has important public health takeaway

EQRx, failed developer of low

CMS got Medicare Advantage quality rating wrong, judge rules

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Sage hopes for a blockbuster in antidepressant now before FDA

EQRx, failed developer of low

entertainment

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Alkermes shareholders re

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Supreme Court strikes down use of affirmative action

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

DIEP, the 'gold standard' of breast reconstruction, is under threat

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Hepatitis C has a cure — but many Americans still lack access to it

ASCO Daily Recap: CAR

entertainment

Data don't support strong claims for Covid

Illumina board agrees to spin off Grail, as divestment plans proceed

5 important ways Henrietta Lacks changed medical science

Finland to offer bird flu vaccine to select groups of people, a possible global first

A new initiative will help leaders fight the next pandemic

EQRx, failed developer of low

knowledge

leisure time

hotspot

hotspot